Chronic heart failure
Conditions
Interventions
Control Group:Standard Oral Drug Therapy for Chronic Heart Failure
Treatment group:Warm acupuncture+Standard Oral Drug Therapy for Chronic Heart Failure
Sponsors
Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital
Eligibility
Sex/Gender
All
Age
60 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Patients who meet the diagnostic criteria of Western medicine and the syndrome differentiation criteria of traditional Chinese medicine, aged between 60 and 85 years, with no restriction on gender. 2. Patients with cardiac function classified as NYHA class II-III. 3. Patients with hemodynamically stable conditions.
Exclusion criteria
Exclusion criteria: 1. Acute myocardial infarction, acute coronary syndrome, cardiac tamponade, cardiogenic shock, and other factors that increase mortality. 2. Patients with severe primary diseases of the brain, liver, kidneys, and hematopoietic system, as well as patients with mental illness. 3. Pregnant or pregnancy-intending women, and breastfeeding women. 4. Patients with a history of needle phobia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Traditional Chinese Medicine (TCM) Yang Deficiency and Blood Stasis Symptom Scoring;Minnesota Heart Failure Quality of Life Questionnaire; | — |
Secondary
| Measure | Time frame |
|---|---|
| NYHA Classification of Heart Function Assessment;6-minute walk test;Peripheral blood detection of B-type natriuretic peptide precursor;SF-36 Health-Related Quality of Life Assessment Scale; | — |
Countries
China
Contacts
Public ContactDing chenhuan
Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital
Outcome results
None listed